• CalciMedica will hold its annual stockholder meeting virtually on Aug. 19, 2026.
• Items include electing two Class III directors, approving changes to the 2023 equity incentive plan, and an advisory vote on executive pay.
• Stockholders will also vote on a reverse stock split in a 1-for-2 to 1-for-10 range with a proportional cut in authorized shares.
• Other votes cover issuing Series A Warrants and Series B Warrants for up to 18,673,429 shares each, plus related share issuance.
• A separate proposal addresses warrant-related issuance tied to directors and officers for up to 1,680,565 shares for each warrant series.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-302112), on July 13, 2026, and is solely responsible for the information contained therein.